L&C Bio Co., Ltd. logo

L&C Bio Co., Ltd. (290650)

Market Open
11 Aug, 06:30
KRX SM KRX SM
65,000. 00
+400
+0.6192%
1.49T Market Cap
- P/E Ratio
200% Div Yield
8,409 Volume
- Eps
64,600
Previous Close
Add Transaction
Day Range
63,400 65,200
Year Range
29,100 125,000
Want to track 290650 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

L&C Bio Co., Ltd. (290650) Statistics

Valuation metrics

Market Cap 1.49T
Enterprise value 1.57T
Trailing P/E (ttm) -10.81
Forward P/E -
PEG ratio 0.06
Price/Sales (ttm) 15.56
Price/Book (mrq) 7.95
Enterprise Value/Revenue 16
Enterprise Value/EBITDA 90.78

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 358.25K
Average volume (90 days) 364.82K

Price summary

52-Week low 29,100
52-Week high 125,000
Beta -
50-Day moving average 71,790
200-Day moving average 74,821.85

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 50
Trailing annual dividend yield 0.0008%
5-Year annual dividend yield -
Payout ratio -0.01
Dividend Date 1 Apr 2026
Ex-Dividend Date 29 Dec 2025
Last split factor 3:1
Last split Date 12 Oct 2020

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin -1.38%
Operating margin 0.11%

Operational effectiveness

Return on assets -0.29%
Return on equity -0.56%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) 3,770.06
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -5,193.67
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 1,869.18
Total debt (mrq) -
Total Debt/Equity (mrq) 0.43
Current ratio (mrq) 0.64%
Book value per share (mrq) 8,194.04

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -